Loading...

IMA IMAGENEBIO INC Capital Structure Changes 8-K Filing

MGNB

M

IMAGENEBIO INC

(IMA)

2026 8-K

Financial Results Announced

Funding Agreement

Management Change

Financial Results Announced

Board Resignation

Management Change

Corporate Presentation Update

Q3 Financial Results

Board Appointment

Service Agreement Update

Management Change

Management Change

Management Changes

Merger of Equals

Merger of Equals

Merger of Equals

Merger of Equals

Merger of Equals

Merger of Equals

Merger Agreement

Appointment of Chief Operat...

Annual Meeting of Stockholders

Discontinuation of Clinical...

Resignation of Chief Medica...

Financial Results and Workf...

Financial Results and Clini...

Special Meeting Approval

Merger Agreement

Delisting Notice

Annual Meeting of Stockholders

Underwriting Agreement for ...

Preclinical Data Announcement

External Links:

On April 12, 2026, ImageneBio, Inc. entered into a $30 million Securities Purchase Agreement to issue pre-funded warrants allowing investors to purchase up to 5,770,335 shares of common stock at $5.199 each, with closing expected by April 14, 2026.

AI Assistant

IMAGENEBIO INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.